ISG has been appointed as the main contractor for University College London’s (UCL) development to create a world leading centre for neurological research. The centre will bring together clinicians and research teams from different disciplines to tackle the neurodegenerative conditions that give rise to dementia, now the leading cause of death in England and Wales.

The new biomedical facility at 256 Gray’s Inn Road will host the central hub of UK Dementia Research Institute (UK DRI) and the University’s leading Queen Square Institute of Neurology (IoN), which will include an NHS Neurology out-patient facility for University College London Hospitals.

UCL’s aim is to provide the most comprehensive, coordinated neuroscience research centre in the world; from research at laboratory benches to patient care.

Neurological diseases, such as dementia, stroke and epilepsy affect four million people in the UK and account for around 13% of global disease prevalence. For more information, please visit the UCL website.